<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Basophil Activation Test to Optimize the Diagnosis of Adverse Effects Following Immunization to Vaccines</title>
    <FirstPage>196</FirstPage>
    <LastPage>202</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Salvatore</FirstName>
        <LastName>Chirumbolo</LastName>
        <affiliation locale="en_US">Laboratory of Physiopathology of Obesity, Department of Medicine, University of Verona, Italy.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Adverse effects&#xA0; following immunization&#xA0; to&#xA0; vaccines (AEFI)&#xA0; are considered&#xA0; extremely rare events, the occurrence of which could gain a major role in optimizing allergy diagnosis by cellular tests. The urgent need to eradicate infectious diseases from population, is the main goal of vaccination campaign, therefore its successful outcome should be almost undisputable. Basophil Activation Test (BAT) is commonly used to ascertain a type I hypersensitivity reaction,&#xA0; often&#xA0; replacing reasability tests.&#xA0; Therefore,&#xA0; flow&#xA0; cytometry assay of&#xA0; basophil,&#xA0; as performed in BATs, is employed to test if a particular antigen elicits some activatory response from cells. The allergic subject may undergo an AEFI to vaccine not necessarily by an atopic reaction with an allergen within vaccines but because of the existence of an asymptomatic or not diagnosed inflammatory chronic allergy or other immune-disregulating allergy disorder in the subject. BAT, also in its basilar fashion, might be used from a simple heparinized&#xA0; whole blood&#xA0; specimen,&#xA0; but&#xA0; its&#xA0; application&#xA0; in&#xA0; diagnosing allergy before&#xA0; mandatory&#xA0; of facultative vaccination, must be associated to improve other diagnostic tools, at least in its pivotal application. If the application of BAT can be suggested to improve allergy diagnosis by introducing a cellular test in routinely used tools, such as sIgE and SPT, its use, due to possible expertise-consuming and relatively expensive issues, can be included in a specialized allergy consultancy panel as an exploratory approach of allergy inflammation, for which a subject undergoing immunization by vaccines is suggested to undergo and advised to sign an informed consent for BAT performing. This may extend BAT use in many other forms of chronic allergy and immunity disorders related to AEFI with vaccines.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/512</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/512/526</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Genetic Polymorphisms in Matrix Metalloproteinases -1 and -7 and Susceptibility to Gastric Cancer: an Association Study and Meta-Analysis</title>
    <FirstPage>203</FirstPage>
    <LastPage>210</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Wen-Liang</FirstName>
        <LastName>Fang</LastName>
        <affiliation locale="en_US">Central Laboratory of Clinical College, Anhui Medical University, Hefei 230601, P. R. China AND Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, P. R. China</affiliation>
      </Author>
      <Author>
        <FirstName>Wei-Bo</FirstName>
        <LastName>Liang</LastName>
        <affiliation locale="en_US">Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, P. R. China</affiliation>
      </Author>
      <Author>
        <FirstName>Lin-Bo</FirstName>
        <LastName>Gao</LastName>
        <affiliation locale="en_US">Laboratory of Molecular Translational Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China</affiliation>
      </Author>
      <Author>
        <FirstName>Bin</FirstName>
        <LastName>Zhou</LastName>
        <affiliation locale="en_US">Laboratory of Molecular Translational Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China</affiliation>
      </Author>
      <Author>
        <FirstName>Feng-Li</FirstName>
        <LastName>Xiao</LastName>
        <affiliation locale="en_US">Central Laboratory of Clinical College, Anhui Medical University, Hefei 230601, P. R. China</affiliation>
      </Author>
      <Author>
        <FirstName>Lin</FirstName>
        <LastName>Zhang</LastName>
        <affiliation locale="en_US">Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, P. R. China AND Laboratory of Molecular Translational Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Matrix Metalloproteinases (MMPs) play an important role in gastric cancer (GC). Accumulated evidence suggests that functional MMP-1 and MMP-7 gene polymorphisms are associated with several tumors. The aim of this study was to investigate two single nucleotide polymorphisms, MMP-1 -1607 1G/2G and MMP-7 -181 A/G, and their potential relationship with GC.
We examined 246 GC&#xA0; patients and 252 age-and sex-matched controls&#xA0; from&#xA0; Sichuan province in China. Genotypes were determined using a polymerase chain reaction-restriction fragment length polymorphism strategy and DNA sequencing. We also performed a meta- analysis of relevant studies, involving 1084 cases and 1721 controls, to place our findings in a broader context.
No significant relationship was observed between the MMP-1 -1607 1G/2G alleles and genotypes and the risk of GC. There were significant differences in the genotypes and allele distributions&#xA0; of&#xA0; the&#xA0; -181 A/G&#xA0; polymorphism&#xA0; of&#xA0; the&#xA0; MMP-7 gene between&#xA0; cases and controls. The -181 A allele carriers had a significantly increased risk of GC compared with 181 G allele carriers (OR=3.051, 95% CI, 1.475-6.310, P=0.002), and the AA genotype of 181 A/G&#xA0; was associated with an increased risk of GC compared with the AG genotype (OR=3.189, 95% CI, 1.523-6.676, P=0.001).
A meta-analysis of six studies also showed a significant risk of GC associated with MMP-7 polymorphism.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/511</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/511/527</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Paraoxonase (PON1) 55 Polymorphism and Association with Systemic Lupus Erythematosus</title>
    <FirstPage>211</FirstPage>
    <LastPage>219</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fariborz</FirstName>
        <LastName>Bahrehmand</LastName>
        <affiliation locale="en_US">Molecular Diagnostic Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Asad</FirstName>
        <LastName>Vaisi-Raygani</LastName>
        <affiliation locale="en_US">Molecular Diagnostic Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran AND&#xA0;&#xA0;Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Ahmadi</LastName>
        <affiliation locale="en_US">Molecular Diagnostic Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Kiani</LastName>
        <affiliation locale="en_US">Department of Pharmacology &#xA0;and Toxicology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zohreh</FirstName>
        <LastName>Rahimi</LastName>
        <affiliation locale="en_US">Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran AND Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Heidar</FirstName>
        <LastName>Tavilani</LastName>
        <affiliation locale="en_US">Department of Clinical Biochemistry, Hamadan University of Medical Sciences, Hamadan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Tayebeh</FirstName>
        <LastName>Pourmotabbed</LastName>
        <affiliation locale="en_US">Department of Microbiology, Immunology and Biochemistry, University of Tennessee, Health Science Center, Tennessee, USA.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Paraoxonase-1 (PON1) is a serum HDL-bound enzyme that hydrolyzes a number of aromatic carboxylic acid esters including lipid peroxides, preventing LDL oxidation. Systemic lupus erythematosus (SLE) patients are at greater risk of oxidative stress, which is associated with abnormal plasma lipid metabolism. In this study, association of PON-55 polymorphism with serum arylesterase (ARE) activities, malondialdehyde (MDA), neopterin, lipids and lipoproteins levels in SLE patients and the development of hypertension was investigated. The present case-control study consisted of 109 SLE patients with and without high blood pressure (BP) and 103 healthy controls from the population in the west of Iran. PON-55 Met&lt;Leu polymorphism was detected by restriction fragment length polymorphism (PCR-RFLP), serum ARE activity, MDA, neoptrin, lipid and apolipoprotein levels were determined by spectrophotometery and HPLC and enzyme assay, respectively. The presence of PON-55 M/M genotype was found to be associated with SLE and the development of high BP. The SLE patients with PON-M (M/L+M/M) allele had significantly lower serum ARE activity, but higher neoptrin and LDL-C than the carriers of corresponding genotypes in control group. The ARE activity was positively correlated with HDL-C and negatively correlated with LDL-C and MDA levels in SLE patients. Whereas, in SLE patients with high BP, ARE activity was only found to be negatively correlated with MDA concentration. These data suggest that PON-55 M/M genotype is a risk factor for SLE. The carriers of this allele have high levels of MDA, neopterin and LDL-C, thus, they are more likely to develop hypertension.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/510</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/510/528</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Impact of Atmospheric Pollutants on the Prevalence of Atopic Eczema in 6-7-Year-Old Schoolchildren in Spain; ISAAC Phase III</title>
    <FirstPage>220</FirstPage>
    <LastPage>227</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mar&#xED;a Morales</FirstName>
        <LastName>Su&#xE1;rez-Varela</LastName>
        <affiliation locale="en_US">Unit of Public Health, Hygiene, and Environmental Care, Department of Preventive Medicine, University of Valencia, Valencia, Spain AND CIBER Epidemiology and Public Health (CIBERESP), Spain AND Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Amparo</FirstName>
        <LastName>Gallardo-Juan</LastName>
        <affiliation locale="en_US">Section of Radiology, General Hospital, Valencia. Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Lu&#xED;s</FirstName>
        <LastName>Garc&#xED;a-Marcos</LastName>
        <affiliation locale="en_US">Pediatric Respiratory Medicine and Allergy Units, 'Virgen de la Arrixaca' University Children's Hospital, University of Murcia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Natalia</FirstName>
        <LastName>Gimeno-Clemente</LastName>
        <affiliation locale="en_US">Unit of Public Health, Hygiene, and Environmental Care, Department of Preventive Medicine, University of Valencia, Valencia, Spain AND CIBER Epidemiology and Public Health (CIBERESP), Spain AND Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Angel L&#xF3;pez</FirstName>
        <LastName>Silvarrey-Varela</LastName>
        <affiliation locale="en_US">Foundation Mar&#xED;a Jos&#xE9; Jove, A Coru&#xF1;a, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>I&#xF1;aqui</FirstName>
        <LastName>Miner-Canflanca</LastName>
        <affiliation locale="en_US">Department of Paediatrics, Hospital de Donostia, San Sebasti&#xE1;n, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Jos&#xE9;</FirstName>
        <LastName>Batlles-Garrido</LastName>
        <affiliation locale="en_US">Department of Paediatrics, Hospital Torrec&#xE1;rdenas, Almer&#xED;a, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Alfredo</FirstName>
        <LastName>Blanco-Quiros</LastName>
        <affiliation locale="en_US">Department of Paediatrics, University of Valladolid, Valladolid, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Rosa Mar&#xED;a</FirstName>
        <LastName>Busquets-Monge</LastName>
        <affiliation locale="en_US">Department of Paediatrics, Hospital del Mar, Barcelona, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Bego&#xF1;a</FirstName>
        <LastName>Dom&#xED;nguez-Aurrecoechea</LastName>
        <affiliation locale="en_US">Health Centre of Otero, Oviedo, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Alberto</FirstName>
        <LastName>Arnedo-Pena</LastName>
        <affiliation locale="en_US">Section of Epidemiology, Centre of Public Health, Regional Ministry of Health, Castell&#xF3;n, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Carlos</FirstName>
        <LastName>Gonz&#xE1;lez-D&#xED;az</LastName>
        <affiliation locale="en_US">Unit of Paediatric Allergy, Department of Paediatrics, Hospital of Basurto, Bilbao, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>In&#xE9;s</FirstName>
        <LastName>Aguinaga-Ontoso</LastName>
        <affiliation locale="en_US">Department of Health Sciences, Public University of Navarra, Navarra, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Antonio</FirstName>
        <LastName>Mart&#xED;nez-Gimeno</LastName>
        <affiliation locale="en_US">Department of Pediatrics, "Santa Luc&#xED;a" University Hospital, Cartagena, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Agust&#xED;n</FirstName>
        <LastName>Llopis-Gonz&#xE1;lez</LastName>
        <affiliation locale="en_US">Unit of Public Health, Hygiene, and Environmental Care, Department of Preventive Medicine, University of Valencia, Valencia, Spain AND CIBER Epidemiology and Public Health (CIBERESP), Spain AND Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Atopic Eczema (AE) is a chronic inflammatory skin disease that affects children and adults, and alters quality of life with a high morbidity rate and severe economic burden. The objective of the present work was to analyse specific atmospheric pollutants (O3, NO, PM10 and SO2) affecting the prevalence of diagnosed AE and its symptoms among 6-7-year-old schoolchildren.
The participants included 21311 schoolchildren aged 6-7 years from 8 Spanish regions, whose parents completed the ISAAC Phase III questionnaire to ascertain AE diagnosis and symptoms. The mean levels (&#xB5;g/m3) of O3, NO, PM10 (particles 10 micrometers or less in diameter) and SO2 were determined in each geographical area participating in this study.
&#xA0;According&#xA0; to&#xA0; these&#xA0; mean&#xA0; levels, three&#xA0; levels of&#xA0; exposure&#xA0; to&#xA0; each&#xA0; pollutant&#xA0; were considered: level 1 (percentiles 0-25); level 2 (percentiles 26-74); level 3 (percentiles 75-100). Exposure to O3&#xA0; was associated with increased prevalence of rashes (exposure level 2, Odds Ratio (OR): 1.22, 95% Confidence Interval (95%CI): 1.02-1.45; level 3 OR:&#xA0; 1.33, 95%CI:1.10-1.61) and diagnosed AE (level 2, OR: 1.27, 95%CI: 1.17-1.39; level 3 OR: 1.27, 95%CI:1.15-1.41). An association was found between the level of NO and a drop in the prevalence of diagnosed AE (exposure level 2, OR: 0.88, 95%CI: 0.81-0.95; level 3 OR: 0.85, 95%CI:0.74-0.97). There was also an association between the highest exposure level to PM10 and a reduced prevalence of rashes (level 3 OR: 0.42, 95%CI: 0.22-0.81) and diagnosed AE (level 3OR: 0.53, 95%CI: 0.38-0.75).
Future studies into exposure to&#xA0; O3&#xA0;&#xA0; and its relationship with allergic diseases may be conducted in order to prevent this association.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/509</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/509/529</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Human Mesenchymal Stem Cells Elevate CD4+CD25+CD127low/- Regulatory T Cells of Asthmatic Patients via Heme Oxygenase-1</title>
    <FirstPage>228</FirstPage>
    <LastPage>235</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Jian-guo</FirstName>
        <LastName>Li</LastName>
        <affiliation locale="en_US">Department of Respirology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Respiratory Disease Research Institute of Sun Yat-Sen University, Guangzhou, Guangdong province, People&#x2019;s Republic of China</affiliation>
      </Author>
      <Author>
        <FirstName>Yong-xun</FirstName>
        <LastName>Zhuan-sun</LastName>
        <affiliation locale="en_US">Department of Respirology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Respiratory Disease Research Institute of Sun Yat-Sen University, Guangzhou, Guangdong province, People&#x2019;s Republic of China</affiliation>
      </Author>
      <Author>
        <FirstName>Bing</FirstName>
        <LastName>Wen</LastName>
        <affiliation locale="en_US">Department of Respirology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Respiratory Disease Research Institute of Sun Yat-Sen University, Guangzhou, Guangdong province, People&#x2019;s Republic of China</affiliation>
      </Author>
      <Author>
        <FirstName>Hao</FirstName>
        <LastName>Wu</LastName>
        <affiliation locale="en_US">Department of Emergency, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Respiratory Disease Research Institute of Sun Yat-Sen University, Guangzhou, Guangdong province, People&#x2019;s Republic of China</affiliation>
      </Author>
      <Author>
        <FirstName>Feng-ting</FirstName>
        <LastName>Huang</LastName>
        <affiliation locale="en_US">Department of Gastroenterology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Respiratory Disease Research Institute of Sun Yat-Sen University, Guangzhou, Guangdong province, People&#x2019;s Republic of China</affiliation>
      </Author>
      <Author>
        <FirstName>Hridaya bibhu</FirstName>
        <LastName>Ghimire</LastName>
        <affiliation locale="en_US">Department of Respirology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Respiratory Disease Research Institute of Sun Yat-Sen University, Guangzhou, Guangdong province, People&#x2019;s Republic of China</affiliation>
      </Author>
      <Author>
        <FirstName>Pi-xin</FirstName>
        <LastName>Ran</LastName>
        <affiliation locale="en_US">Department of Respirology, The First Affiliated Hospital of Guang Zhou Medical College, Guangzhou, Guangdong province, People&#x2019;s Republic of China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Up-regulation of CD4+CD25+CD127low/- regulatory T cells (Tregs) is a new target in the treatment of asthma. Human bone marrow mesenchymal stem cells can up-regulate CD4+CD25+CD127low/- regulatory T cells in vitro,&#xA0; meanwhile, heme oxygenase-1 (HO-1) plays an important role in the development and maintenance of CD4+CD25+ regulatory T cells. However the mechanism has not yet been adequately understood. Hence, we wondered what effect of Heme Oxygenase-1 made on regulation of CD4+CD25+CD127low/-&#xA0; regulatory T cells mediated by mesenchymal stem cells.
Peripheral blood mononuclear cells isolated from asthmatic patients and healthy controls were co-cultured with human bone marrow mesenchymal stem cells which were pretreated with Hemin (the revulsive of Heme Oxygenase-1), Protoporphyrin &#x2168; zinc (the inhibitor of Heme Oxygenase-1) and saline.
The expression of Heme Oxygenase-1 in MSCs was enhanced by Hemin and inhibited by Protoporphyrin&#xA0; zinc in vitro. Overexpression of Heme Oxygenase-1 elevated the proportion of CD4+CD25+CD127low/- regulatory T cells in CD4+ T cells, meanwhile, inhibition of Heme Oxygenase-1 decreased the proportion of CD4+CD25+CD127low/- regulatory T cells in CD4+ T cells as compared with mesenchymal stem cells alone.
Taken together, these data demonstrated that Heme Oxygenase-1 contributed to the up-regulation of CD4+CD25+CD127low/- regulatory T cells mediated by mesenchymal stem cells in asthma.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/508</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/508/530</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Frequency Analysis of Capnogram Signals to Differentiate Asthmatic and Non-asthmatic Conditions Using Radial Basis Function Neural Networks</title>
    <FirstPage>236</FirstPage>
    <LastPage>246</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Kazemi</LastName>
        <affiliation locale="en_US">Department of Biotechnology and Medical Engineering, Faculty of Bioscience and Medical Engineering, Universiti Teknologi Malaysia, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Malarvili</FirstName>
        <LastName>Bala Krishnan</LastName>
        <affiliation locale="en_US">Department of Biotechnology and Medical Engineering, Faculty of Bioscience and Medical Engineering, Universiti Teknologi Malaysia, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Teo</FirstName>
        <LastName>Aik Howe</LastName>
        <affiliation locale="en_US">Emergency Department, Hospital Pulau Pinang, Pinang, Malaysia</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">In this paper, the method of differentiating asthmatic and non-asthmatic patients using the&#xA0; frequency analysis of&#xA0; capnogram&#xA0; signals is presented.&#xA0; Previously, manual study on capnogram signal has been conducted&#xA0; by several researchers. All past researches showed significant correlation between capnogram signals and asthmatic patients. However all of them are just manual study conducted through the conventional time domain method. In this study, the power spectral density (PSD) of capnogram signals is estimated by using Fast Fourier Transform (FFT) and Autoregressive (AR) modelling.
The&#xA0; results show the&#xA0; non-asthmatic&#xA0; capnograms have one&#xA0; component&#xA0; in their&#xA0; PSD estimation, in contrast to asthmatic capnograms that have two components. Furthermore, there is a significant difference between the magnitude of the first component&#xA0; for both asthmatic and non-asthmatic capnograms.
&#xA0;The&#xA0; effectiveness and&#xA0; performance&#xA0; of&#xA0; manipulating the&#xA0; characteristics of&#xA0; the&#xA0; first frequency&#xA0; component,&#xA0; mainly its&#xA0; magnitude&#xA0; and&#xA0; bandwidth,&#xA0; to&#xA0; differentiate&#xA0; between asthmatic and non-asthmatic conditions by means of receiver operating characteristic (ROC) curve analysis and radial basis function (RBF) neural network were shown.
The output of this network is an integer prognostic index from 1 to 10 (depends on the severity of asthma) with an average good detection rate of 95.65% and an error rate of 4.34%. This developed algorithm is aspired to provide a fast and low-cost diagnostic system to&#xA0; help&#xA0; healthcare professional involved in respiratory care as it would be&#xA0; possible to monitor severity of asthma automatically and instantaneously.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/507</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/507/532</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Relationship between Serum YKL-40 Levels and Severity of Asthma</title>
    <FirstPage>247</FirstPage>
    <LastPage>253</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Serap</FirstName>
        <LastName>Duru</LastName>
        <affiliation locale="en_US">D&#x131;&#x15F;kap&#x131; Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t Education and Research Hospital, Chest Diseases Clinic, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>G&#xFC;lbahar</FirstName>
        <LastName>Y&#xFC;ce</LastName>
        <affiliation locale="en_US">Etlik &#x130;htisas Education and Research Hospital, Chest Diseases Clinic, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Sevinc Sarinc</FirstName>
        <LastName>Ulasli</LastName>
        <affiliation locale="en_US">Afyon Kocatepe University, School of Medicine, Department of Pulmonary Diseases, Afyon, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Melike</FirstName>
        <LastName>Erdem</LastName>
        <affiliation locale="en_US">D&#x131;&#x15F;kap&#x131; Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t Education and Research Hospital, Chest Diseases Clinic, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Murat</FirstName>
        <LastName>Kizilg&#xFC;n</LastName>
        <affiliation locale="en_US">Ankara Pediatrics Hematology and Oncology Hospital, Department of Biochemistry, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Fatma</FirstName>
        <LastName>Kara</LastName>
        <affiliation locale="en_US">Ankara Pediatrics Hematology and Oncology Hospital, Department of Biochemistry, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Sad&#x131;k</FirstName>
        <LastName>Ard&#x131;c</LastName>
        <affiliation locale="en_US">D&#x131;&#x15F;kap&#x131; Y&#x131;ld&#x131;r&#x131;m Beyaz&#x131;t Education and Research Hospital, Chest Diseases Clinic, Ankara, Turkey</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">YKL-40 (chitinase-3-like-1) has been introduced as a marker of inflammation in asthma. The aim of this study was to determine the role of YKL-40 in asthma and to evaluate the relationship between YKL-40 and asthma severity.
In the study, 60 non-smoker asthma patients without additional diseases (aged between 20-60 years, female: 34) were grouped [Group I: Well controlled asthma patients (n: 30), Group II: Patients during acute exacerbation of asthma (n: 30)]. Healthy non-smoker female individuals were included in Group III (n: 30) as a control group. The level of serum YKL-40 of all groups were determined by ELISA. Also, serum YKL- 40 level was correlated with age, asthma duration in years, body mass index (BMI), forced expiratory volume in first second/ forced vital capacity (FEV1/FVC, %), FEV1 (%), and total IgE levels of asthma patients.
Mean serum YKL-40 level was highest in patients during acute exacerbation of asthma (36.36&#xB1;10.49 ng/ml) while mean serum YKL-40 level was the lowest (13.20&#xB1;5.60 ng/ml) in the control group. There was a negative significant correlation between the serum YKL-40 levels and&#xA0; FEV1&#xA0; (%)&#xA0; in&#xA0; patients&#xA0; during&#xA0; acute&#xA0; exacerbation&#xA0; of&#xA0; asthma.&#xA0; There&#xA0; were no significant correlations between the serum YKL-40 levels and other variables in group II.
We found that increased serum YKL-40 levels may be used as a marker for evaluation of asthma severity and genetic polymorphism.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/506</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/506/533</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Oral Health Status in Preschool Asthmatic Children in Iran</title>
    <FirstPage>254</FirstPage>
    <LastPage>261</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Ehsani</LastName>
        <affiliation locale="en_US">Dental Student&#x2019;s Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Moin</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ghasem</FirstName>
        <LastName>Meighani</LastName>
        <affiliation locale="en_US">Department of Pediatric Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Jalal</FirstName>
        <LastName>Pourhashemi</LastName>
        <affiliation locale="en_US">Department of Pediatric Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hadi</FirstName>
        <LastName>Khayatpisheh</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nazli</FirstName>
        <LastName>Yarahmadi</LastName>
        <affiliation locale="en_US">Department of Pediatric Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Asthma is a chronic inflammatory disorder of the airways, which is diagnosed by periodic symptoms of inflammation, bronchial spasm, and increased mucosal secretions. It has higher incidence among the preschool children. There are many contradictory reports based on the effect of asthma on oral health, however it has been hypothesized that asthma could lead to poor oral health. The objective of the present study was to investigate oral health indices in 44 preschool children of three to six years old with mild to moderate asthma and 46 matched healthy children in Tehran Children's Respiratory Center.
Dental plaque, gingival inflammation, mouth breathing, and dental caries were evaluated by one trained examiner according to World Health Organization [WHO] criteria. Culture and colony counting of streptococcus mutans and lactobacillus species were carried out in saliva specimens of the patients. The effects of different factors on the colony counts were statistically analyzed using linear regression analysis.
The level of mother&#x2019;s education and preexisting asthma disease in children had significant effect&#xA0; on&#xA0; the&#xA0; colony counts&#xA0; of&#xA0; streptococcus&#xA0; species whereas no&#xA0; factor&#xA0; was found&#xA0; to influence the number of lactobacillus counts significantly. The results indicated no significant differences between the children with asthma and those without asthma regarding (decayed, missing, filled, teeth) dmft index (mean of 3.34 in asthmatic children and 3.0 in the control group).
Therefore, it can be deduced that the presence of asthma disease did not increase the probability of tooth decay.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/505</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/505/534</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Comparison of the Th1, IFN-&#x3B3; Secreting Cells and FoxP3 Expression between Patients with Stable Graft Function and Acute Rejection Post Kidney Transplantation</title>
    <FirstPage>262</FirstPage>
    <LastPage>268</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Banafsheh</FirstName>
        <LastName>Nazari</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Aliakbar</FirstName>
        <LastName>Amirzargar</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran AND&#xA0; Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behrouz</FirstName>
        <LastName>Nikbin</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran AND&#xA0; Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Nafar</LastName>
        <affiliation locale="en_US">Department of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti Medical University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Pedram</FirstName>
        <LastName>Ahmadpour</LastName>
        <affiliation locale="en_US">Department of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti Medical University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behzad</FirstName>
        <LastName>Einollahi</LastName>
        <affiliation locale="en_US">Department of Nephrology, Baqiyatallah University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahboob</FirstName>
        <LastName>Lesan Pezeshki</LastName>
        <affiliation locale="en_US">Department of Nephrology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyyed Mohammad Reza</FirstName>
        <LastName>Khatami</LastName>
        <affiliation locale="en_US">Department of Nephrology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Bita</FirstName>
        <LastName>Ansaripour</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Nikuinejad</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Mohamadi</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Samaneh</FirstName>
        <LastName>Soltani</LastName>
        <affiliation locale="en_US">Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Nicknam</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran AND&#xA0; Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">There are limited clinical investigations identifying the percentage of T helper 1 (Th1) and T regulatory (Treg) cells in stable as well as rejected kidney allografts, a concept which needs to be more studied. The aim of our study was to compare the percentage of CD4+ IFN-&#x3B3;+ cells, the number of IFN-&#x3B3; secreting cells and the amount of FoxP3 expression in patients with or without stable graft function, to determine the roles of these immunological factors in stable and rejected renal allografts. In this prospective study, 3 months after transplantation 30 patients who received renal transplants from unrelated living donors were enrolled and divided into two groups, 20 patients with stable graft function and 10 patients with biopsy proven acute rejection. The percentage of Th1 CD4+ IFN-&#x3B3;+ cells was determined on PBMC by flow cytometry and the number of IFN-&#x3B3; secreting cells by ELISPOT method. Furthermore, FoxP3 expression of PBMCs was measured by Real Time PCR method. The results of these assessments in both groups were statistically analyzed by SPSS 14.0. Our results showed that the percentage of Th1 CD4+ IFN-&#x3B3;+ cells and the number of IFN-&#x3B3; secreting cells were significantly higher in the patients with acute rejection in comparison to the stable graft function group (p&lt;0.001). In addition, the level of FoxP3 gene expression was higher in the group with stable graft compared to the acute rejection group. The higher percentage of CD4+ IFN-&#x3B3;+Th1 subset and number of IFN-&#x3B3; secreting cells and also the lower expression of Foxp3 could prone the patients to acute rejection episode post transplantation. By these preliminary data, it is suggested that monitoring of Th1 cells post transplantation, as an immunologic marker could predict the possibility of rejection episodes.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/504</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/504/535</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Mutation Hot Spots in Hepatitis B Surface Antigen in Chronic Carriers from Khoozestan Province, Southern of Iran</title>
    <FirstPage>269</FirstPage>
    <LastPage>275</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Ramezani</LastName>
        <affiliation locale="en_US">Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Norouzi</LastName>
        <affiliation locale="en_US">Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Gholam Reza</FirstName>
        <LastName>Sarizade</LastName>
        <affiliation locale="en_US">Khoozestan Province Blood Trasfusion, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Vahdat</FirstName>
        <LastName>Poortahmasebi</LastName>
        <affiliation locale="en_US">Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ebrahim</FirstName>
        <LastName>Kalantar</LastName>
        <affiliation locale="en_US">Gholhak Medical Laboratory, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Lars</FirstName>
        <LastName>Magnius</LastName>
        <affiliation locale="en_US">Virological Department, Swedish Institute for Infectious Disease Control, Solna, Sweden</affiliation>
      </Author>
      <Author>
        <FirstName>Helen</FirstName>
        <LastName>Norder</LastName>
        <affiliation locale="en_US">Virological Department, Swedish Institute for Infectious Disease Control, Solna, Sweden</affiliation>
      </Author>
      <Author>
        <FirstName>Esteban</FirstName>
        <LastName>Domingo</LastName>
        <affiliation locale="en_US">Centro de Biolog&#xED;a Molecular, Severo Ochoa, (CSIC-UAM), Universidad Aut&#xF3;noma de Madrid, Cantoblanco, Madrid, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Mohammad</FirstName>
        <LastName>Jazayeri</LastName>
        <affiliation locale="en_US">Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Mutations in the human hepatitis B virus (HBV) genome contribute to its escape from host immune surveillance and result in persistent infections. The aim of this study was to characterize the molecular variations of the surface gene and protein in chronically-infected patients from the southern part of Iran.
The&#xA0; surface&#xA0; genes&#xA0; from&#xA0; 12&#xA0; HBV&#xA0; chronic&#xA0; carriers&#xA0; were&#xA0; amplified, sequenced&#xA0; and subsequently aligned using international and national Iranian database.
All strains belonged to genotype D, subgenotype D1 and subtype ayw2. Of all 30 muta-tions occurred at 22 nucleotide positions, 18 (60%) were missense (amino acid altering) and 12 (40%) were silent (no amino acid changing). The mean mutation frequency (missense to silent nucleotide ratio), was 1.5, indicating application of a high positive selection pressure on the surface proteins. At the amino acid level, of 17 substitutions, 15 (88%) occurred in different immune epitopes within surface protein, of which 7 (46.6%) in B cell epitopes in 5 residues; 7 (46.6%) in T helper epitopes in 6 positions; 1 (7%) in inside CTL epitopes in 1 residue.
We therefore conclude that the distribution of 93.2% of amino acid mutations inside B and T helper immune epitopes as well as the ratio between silent and missense nucleotide mutations showed a positive, focused immune selection pressure on the surface protein, which led to the evolution and emergence of escape mutants in these patients.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/503</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/503/537</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Low and High CD8 Positive T cells in Multiple Sclerosis Patients</title>
    <FirstPage>276</FirstPage>
    <LastPage>280</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Izad</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Harirchian</LastName>
        <affiliation locale="en_US">Iranian Neurological Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Amiri</LastName>
        <affiliation locale="en_US">Iranian Neurological Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farangis</FirstName>
        <LastName>Najafi</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Ghaflati</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Salehi</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Cumulating evidence points to a key role for CD8+ T cells in the pathogenesis of multiple sclerosis.CD8 expression level was believed to be present constantly on the surface of human peripheral blood T cells. However, it was shown that peripheral blood lymphocytes may be divided by the level of CD8 expression, into CD8+high and CD8+low T cells. Now it is well established that the CD8low population of CD8+ T cells demonstrates an activated effector phenotype while the CD8+high T cells have been reported to have regulatory function. In this report we used a flow cytometric assay to compare the frequency of these two subsets in multiple sclerosis patients (n=31) with healthy age- and gender-matched controls (n=18). We found that CD8+ T cells and CD8+low T cells significantly increased in secondary progressive (SP) and primary progressive multiple sclerosis (PPMS) patients in comparison to controls (p&lt;0.0002 and p&lt;0.004 respectively) and also RRMS (p&lt;0.005 and p&lt;0.017 respectively). These results demonstrated the role of CD8low T cells in progressive form of multiple sclerosis.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/502</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/502/538</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effects of Intranasal Phototherapy on Nasal Microbial Flora in Patients with Allergic Rhinitis</title>
    <FirstPage>281</FirstPage>
    <LastPage>286</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Yavuz Selim</FirstName>
        <LastName>Y&#x131;ld&#x131;r&#x131;m</LastName>
        <affiliation locale="en_US">Department of Otorhinolaryngology and Head and Neck Surgery, Medical Faculty, Bezmialem Vakif University, &#x130;stanbul, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Tayfun</FirstName>
        <LastName>Apuhan</LastName>
        <affiliation locale="en_US">Abant Izzet Baysal University, Medical Faculty, Department of ENT, Bolu, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Esra</FirstName>
        <LastName>Ko&#xE7;o&#x11F;lu</LastName>
        <affiliation locale="en_US">Abant Izzet Baysal University, Medical Faculty, Department of Microbiology and Clinical Microbiology, Bolu, Turkey</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The objective of this study was to investigate the effect of intranasal phototherapy on nasal microbial flora in patients with allergic rhinitis.
This prospective, self-comparised, single blind study was performed on patients with a history of at least two years of moderate-to-severe perennial allergic rhinitis that was not controlled&#xA0; by&#xA0; anti-allergic drugs.&#xA0; Thirty-one&#xA0; perennial&#xA0; allergic rhinitis&#xA0; patients&#xA0; were enrolled in this study. Before starting the test population on their intranasal phototherapy, the same trained person took a nasal culture from each subject by applying a sterile cotton swab&#xA0; along&#xA0; each&#xA0; side&#xA0; of&#xA0; the&#xA0; nostril&#xA0; and&#xA0; middle&#xA0; meatus.&#xA0; Each&#xA0; intranasal&#xA0; cavity was irradiated three times a week for two weeks with increasing doses of irradiated. At the end&#xA0; of&#xA0; the&#xA0; intranasal phototherapy,&#xA0; nasal cultures were again obtained&#xA0; from&#xA0; the&#xA0; each nostril The study found that after intranasal phototherapy, the scores for total nasal symptoms decreased significantly but bacterial proliferation was not significantly different before and after phototherapy.
We&#xA0; have&#xA0; shown&#xA0; that&#xA0; intranasal&#xA0; phototherapy&#xA0; does&#xA0; not&#xA0; change&#xA0; the&#xA0; aerobic&#xA0; nasal microbial flora in patients with perennial allergic rhinitis.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/501</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/501/539</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Autism in a Child with Common Variable Immunodeficiency</title>
    <FirstPage>287</FirstPage>
    <LastPage>289</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Salehi Sadaghiani</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Asghar</FirstName>
        <LastName>Aghamohammadi</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmoud-Reza</FirstName>
        <LastName>Ashrafi</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Firozeh</FirstName>
        <LastName>Hosseini</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Abolhassani</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran AND Molecular Immunology Research Center, Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Autism is a neurodevelopmental disorder, characterized by poor social interaction and communication impairment and repetitive behavior. Autism is considered as a genetic and multifactorial disorder, with diverse risk factors involved.
Herein, we report a 13-year-old male with common variable immunodeficiency (CVID), who was diagnosed with autism at the age of 3 years old.
As&#xA0; there&#xA0; are&#xA0; some&#xA0; evidences about&#xA0; the&#xA0; role of&#xA0; the&#xA0; immune&#xA0; system defects&#xA0; in&#xA0; the pathogenesis of autism, specific primary antibody deficiency diseases such as CVID might predispose some affected cases to this neurodevelopmental disorders.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/500</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/500/540</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Osteoimmunology and Nutritional Science</title>
    <FirstPage>290</FirstPage>
    <LastPage>291</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mahshid</FirstName>
        <LastName>Sirjani</LastName>
        <affiliation locale="en_US">Department of Clinical Nutrition and Dietetics, School of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Science and Health Service, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">LETTER TO THE EDITOR</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/499</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/499/541</pdf_url>
  </Article>
</Articles>
